Overview NasoNeb Delivery of an Intranasal Steroid Status: Completed Trial end date: 2012-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to see if a nasal steroid drug delivered to the nose with the NasoNeb™ inhaler improves the symptoms of people with perennial allergic rhinitis (year round allergy symptoms). Phase: Phase 4 Details Lead Sponsor: University of ChicagoCollaborator: MedInvent, LLCTreatments: Budesonide